PRL antibody
Ref. 3D-10R-5446
| 100µl | 1.084,00 € |
Produktinformation
The PRL antibody is a monoclonal antibody known as trastuzumab. It is used in the treatment of certain types of cancer, particularly breast cancer that overexpresses the HER2 protein. This antibody works by binding to the HER2 receptors on cancer cells, inhibiting their growth and promoting cell death. In addition to its anti-cancer properties, trastuzumab has been shown to have other therapeutic effects. It can enhance the activity of lysozyme, an enzyme involved in immune defense, and stimulate tyrosine kinase receptors, which play a role in cell growth and development. Furthermore, trastuzumab has been found to inhibit insulin-like growth factor signaling and dopamine release, both of which are implicated in tumor progression. Overall, this monoclonal antibody offers targeted therapy for HER2-positive cancers and holds promise for improving patient outcomes.
Chemische Eigenschaften
Technische Anfrage zu: 3D-10R-5446 PRL antibody
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
